search
Back to results

Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis

Primary Purpose

Chronic Arsenic Poisoning

Status
Completed
Phase
Phase 2
Locations
Bangladesh
Study Type
Interventional
Intervention
Neem plus propylene glycol plus salicylic acid
Salicylic acid
Sponsored by
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Arsenic Poisoning

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age: 18-60 years
  • Palmar arsenical keratosis
  • Drinking arsenic contaminated water (>50 µg/L) for more than six months
  • Patient voluntarily agree to participate

Exclusion Criteria:

  • Pregnancy and lactating mother
  • Skin lesion :Psoriasis and eczema
  • Bowen's disease
  • Any kind of systemic disease, inflammatory disease and infectious condition that affect skin (Diabetes mellitus, Rheumatoid arthritis, Systemic lupus erythematosus , Hepatitis and Tuberculosis)
  • Hypersensitivity to any drug
  • Patient who received treatment within last three months

Sites / Locations

  • Muradnagar Health Complex

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Patients treated with 3 drugs

Patients treated with 1 drug

Arm Description

Neem plus propylene glycol plus salicylic acid: Neem extract, propylene glycol (40%) and salicylic acid (10%) once daily on palm for 12 weeks

Salicylic acid once daily on palm for 12 weeks

Outcomes

Primary Outcome Measures

Changes in palmer arsenical keratosis
Size of keratotic lesion will be decreased

Secondary Outcome Measures

Changes in arsenic level in nail
Arsenic level in nail will be decreased

Full Information

First Posted
January 28, 2015
Last Updated
January 11, 2016
Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
search

1. Study Identification

Unique Protocol Identification Number
NCT02352987
Brief Title
Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis
Official Title
Randomized, Single Blind, Placebo Controlled Clinical Trial to See the Effect of Combination of Neem, Propylene Glycol and Salicylic Acid in the Treatment of Arsenical Palmar Keratosis
Study Type
Interventional

2. Study Status

Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
March 2015 (undefined)
Primary Completion Date
September 2015 (Actual)
Study Completion Date
September 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is designed to find out the effectiveness of combination of ethanol extract of neem leaf, propylene glycol (40%) and salicylic acid (10%) in the treatment of palmar arsenical keratosis.
Detailed Description
Arsenic, a non-essential trace element, is a major water pollutant in Bangladesh. Arsenical keratosis, which occurs in the palm and sole, is a common symptom of arsenicosis. The objective of this study is to find the effectiveness of combination of topical administration of the ethanol extract of leaf of neem (Azadirachta indica), propylene glycol (40%) and salicylic acid (10%) in the treatment of palmar arsenical keratosis. On the basis of inclusion and exclusion criteria, 30 patients of moderate palmar arsenical keratosis will be recruited from an arsenic affected area. They will be divided into two groups: study group and placebo comparator group. Each group consisting of 15 members. Study group will be given combination of ethanol extract of leaf of neem, propylene glycol (40%) and salicylic acid (10%) to apply on palm overnight once daily for 12 weeks. On the other hand placebo comparator group will be given salicylic (10%) acid to apply on palm overnight once daily for 12 weeks. Water and nail samples will be collected before starting recruitment to confirm arsenicosis. After conclusive recruitment of the subjects the objective, nature, purpose and potential risks and benefits of all procedures of the study will be explained in details to the patients and informed written consent will be taken from them. Detail history, clinical examination and photograph (palm) will also be collected. Clinical improvement will be assessed by measuring palmar nodular size on both hands, before starting treatment and after 12 weeks completion of treatment and perception of patients about their improvement. The study will explore the effectiveness of topical use of combination of ethanol extract of neem, propylene glycol and salicylic acid for the treatment of palmar arsenical keratosis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Arsenic Poisoning

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients treated with 3 drugs
Arm Type
Experimental
Arm Description
Neem plus propylene glycol plus salicylic acid: Neem extract, propylene glycol (40%) and salicylic acid (10%) once daily on palm for 12 weeks
Arm Title
Patients treated with 1 drug
Arm Type
Active Comparator
Arm Description
Salicylic acid once daily on palm for 12 weeks
Intervention Type
Drug
Intervention Name(s)
Neem plus propylene glycol plus salicylic acid
Other Intervention Name(s)
In house prepared
Intervention Description
Leaf extract of neem plus propylene glycol (40%) plus salicylic acid (10%) will be applied on palmar keratotic lesion once daily at bedtime for 12 weeks
Intervention Type
Drug
Intervention Name(s)
Salicylic acid
Other Intervention Name(s)
In house prepared
Intervention Description
salicylic acid (10%) will be applied on palmar keratotic lesion once daily at bedtime for 12 weeks
Primary Outcome Measure Information:
Title
Changes in palmer arsenical keratosis
Description
Size of keratotic lesion will be decreased
Time Frame
0 weeks (baseline), 12 weeks (end)
Secondary Outcome Measure Information:
Title
Changes in arsenic level in nail
Description
Arsenic level in nail will be decreased
Time Frame
0 weeks (baseline), 12 weeks (end)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age: 18-60 years Palmar arsenical keratosis Drinking arsenic contaminated water (>50 µg/L) for more than six months Patient voluntarily agree to participate Exclusion Criteria: Pregnancy and lactating mother Skin lesion :Psoriasis and eczema Bowen's disease Any kind of systemic disease, inflammatory disease and infectious condition that affect skin (Diabetes mellitus, Rheumatoid arthritis, Systemic lupus erythematosus , Hepatitis and Tuberculosis) Hypersensitivity to any drug Patient who received treatment within last three months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mir Misbahuddin
Organizational Affiliation
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Official's Role
Study Director
Facility Information:
Facility Name
Muradnagar Health Complex
City
Comilla
Country
Bangladesh

12. IPD Sharing Statement

Learn more about this trial

Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis

We'll reach out to this number within 24 hrs